The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease

Mayo Clinic Proceedings

Volumn 78, Issue 6, 2003, Pages 730-731

  Flowers, Charlene M ^a,b   Racoosin, Judith A ^a   Lu, Susan L ^a   Beitz, Julie G ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b HFD 430 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERGOLIDE;

ADULT; AGED; AORTA VALVE DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FOOD AND DRUG ADMINISTRATION; HOSPITALIZATION; HUMAN; MALE; MITRAL VALVE DISEASE; PARKINSON DISEASE; REGISTER; TRICUSPID VALVE DISEASE; VALVULAR HEART DISEASE;

EID: 0038581961     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.6.730     Document Type: Article

References (2)

1. Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE. Valvular heart disease in patients taking pergolide. Mayo Clin Proc. 2002;77:1280-1286.
2. Permax. In: Physicians' Desk Reference. 55th ed. Montvale, NJ: Medical Economics Co Inc; 2001:668-670.